Document is current
Any future updates will be listed below
-
Authors
Roth, Daniel http://orcid.org/0000-0002-4128-0032
Larsson, Erik
Ljungberg, Michael
Sjögreen Gleisner, Katarina
-
Funding
Funding for this research was provided by:
Cancerfonden (180747, 21-1754-Pj01H)
Fru Berta Kamprads Stiftelse (BKS-2020-13-293)
Lund University
- License Information
-
More Information
Article History
Received: 12 January 2022
Accepted: 20 April 2022
First Online: 8 May 2022
Declarations
:
: Not applicable.
: Not applicable.
: KSG and MLj received project funding from Fusion Pharmaceuticals Inc., Canada. DR and EL declare that they have nothing to disclose.
